Research Peptide · Nootropic

Adamax: Adamantane-Modified Semax

📄 4 PubMed citations

A synthetic analog pairing N-acetyl Semax with an adamantane moiety, sold for research and marketed as a sharper, longer-lasting nootropic. No studies on Adamax itself exist — here is the parent-compound science it is extrapolated from.

🔬 Most vendor pages call Adamax a "2–3× stronger Semax" with no citation. HighPeptides separates what is actually measured in Semax / N-acetyl Semax research from what is merely inferred for the adamantane-modified analog — which has zero published studies of its own.
0
Peer-reviewed studies on Adamax specifically
0
Residues in the Semax backbone (ACTH 4–10)
0
Potency vs NA-Semax claimed by vendors (unverified)

How It Works

🧬
ACTH(4–10) Neuropeptide Core

Semax is a heptapeptide analog of the ACTH(4–10) fragment (Met-Glu-His-Phe-Pro-Gly-Pro). Unlike ACTH it carries no corticotropic activity, instead acting on melanocortin and neurotrophic pathways in the central nervous system.

🌱
BDNF / NGF Upregulation

In rats, Semax raises brain-derived neurotrophic factor in the basal forebrain (Dolotov, J Neurochem 2006) and regulates BDNF/trkB in the hippocampus (Brain Res 2006). This neurotrophic signaling is the leading explanation for its cognitive effects.

💧
Adamantane = Lipophilic Anchor

Adamantane is the same rigid, fat-soluble carbon cage found in amantadine and memantine. Bolting it onto the peptide is intended to raise membrane permeability and slow enzymatic breakdown — the basis of the "stronger, longer" marketing. Not demonstrated for Adamax.

🛡️
N-Terminal Acetylation

Acetylating Semax at its N-terminus alters its Cu²⁺/Zn²⁺ coordination and resistance to aminopeptidases (J Inorg Biochem 2016) — an established route to extend a peptide’s half-life in the body.

What the Data Shows

Semax → BDNF in rat basal forebrain
Dolotov et al., J Neurochem 2006 · PMID 16635254
Increased
Semax → BDNF / trkB in hippocampus
Brain Res 2006 · PMID 16996037
Upregulated
Semax in acute ischemic stroke
Russian clinical study · PMID 11517472 / 29798983
Benefit reported
Semax — immune-response genes in ischemia
Mol Genet Genomics 2017 · PMID 28255762
Modulated
Adamax — direct human or animal trials
No peer-reviewed studies located
0

Key Takeaways

✅ What We Know
  • Semax is a real, Russian-developed ACTH(4–10) analog with decades of clinical use there for stroke and cognitive indications.
  • In animal models Semax raises BDNF and NGF-related signaling — the leading mechanism behind its reported nootropic and neuroprotective effects.
  • N-acetylation and lipophilic adamantane groups are established medicinal-chemistry tactics for improving a peptide’s stability and CNS penetration.
  • Adamantane is well characterized pharmacologically through the approved drugs amantadine and memantine.
  • Adamax is handled in research settings intranasally, mirroring how Semax is delivered.
⚠️ What We Don't Know
  • There are no peer-reviewed studies on Adamax itself — efficacy, the "2–3× potency" claim, dosing, and safety are all unverified.
  • Whether the adamantane modification genuinely improves on Semax in humans is unknown.
  • Adamax is not approved by the FDA or any regulator; it is sold for laboratory research only.
  • Long-term safety, drug interactions, and effects on Cu²⁺/Zn²⁺ metal-ion homeostasis have not been studied.
  • Research-peptide identity and purity vary by vendor — what is sold as "Adamax" may not be characterized at all.

Frequently Asked Questions

What is Adamax?

Adamax is a synthetic peptide sold for research use that joins N-acetyl Semax — a modified form of the Russian nootropic peptide Semax (an ACTH 4–10 analog) — to an adamantane group. The adamantane cage is meant to make the molecule more fat-soluble and longer-lasting. No clinical or animal studies on Adamax itself have been published, so its properties are inferred from Semax and from adamantane-containing drugs.

Is Adamax stronger than Semax?

Vendors commonly claim Adamax is 2–3 times more potent than N-acetyl Semax, but no published data supports that figure. It is a chemistry-based prediction: adamantane increases lipophilicity and may slow enzymatic breakdown, which could raise CNS exposure. Whether that translates to a greater effect in humans has never been measured.

What does the Semax research actually show?

Most rigorous Semax data comes from Russia. In rats, Semax increases brain-derived neurotrophic factor in the basal forebrain (J Neurochem 2006, PMID 16635254) and regulates BDNF/trkB in the hippocampus (Brain Res 2006, PMID 16996037). Clinical reports describe benefit in acute ischemic stroke (PMID 11517472, 29798983). These findings are about Semax — not Adamax.

Is Adamax FDA approved or legal to take?

No. Adamax is not approved by the FDA or any other regulator and is not a medicine. It is sold labeled "for laboratory research only," is not approved for human consumption, and its safety in people has not been established.

How is Adamax related to amantadine and memantine?

Only through the shared adamantane group. Amantadine and memantine are adamantane derivatives used as approved drugs, which shows the scaffold is pharmacologically active and tolerated in those specific molecules. That does not transfer to Adamax — sharing a chemical fragment does not mean shared effects or shared safety.

🔬 Research-Grade Source

Swiss Chems publishes third-party HPLC COAs for every batch. HighPeptides' primary vendor reference for peptides.

Browse Swiss Chems →

Affiliate link — supports HighPeptides at no extra cost

⚠️ Disclaimer

Educational purposes only. Not medical advice.

Adamax is sold for laboratory research only. It is not approved for human use by the FDA or any regulator, and no clinical studies on it have been published.

© 2026 HighPeptides · Educational content only · Not medical advice